Persistent complement dysregulation with signs of thromboinflammation in active Long Covid
Science · 19.01.2024 · 383 (6680)
DOI: 10.1126/science.adg7942 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 19.01.2024. Verfasst von Carlo Cervia-Hasler und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland. Hauptthemen laut MEDLINE: Complement Activation, Complement System Proteins, Post-Acute COVID-19 Syndrome, Thromboinflammation. Die Arbeit wurde bisher 433-mal zitiert (Crossref) und nennt 103 Literaturangaben.
Abstract (Originalsprache)
Long Covid is a debilitating condition of unknown etiology. We performed multimodal proteomics analyses of blood serum from COVID-19 patients followed up to 12 months after confirmed severe acute respiratory syndrome coronavirus 2 infection. Analysis of >6500 proteins in 268 longitudinal samples revealed dysregulated activation of the complement system, an innate immune protection and homeostasis mechanism, in individuals experiencing Long Covid. Thus, active Long Covid was characterized by terminal complement system dysregulation and ongoing activation of the alternative and classical complement pathways, the latter associated with increased antibody titers against several herpesviruses possibly stimulating this pathway. Moreover, markers of hemolysis, tissue injury, platelet activation, and monocyte–platelet aggregates were increased in Long Covid. Machine learning confirmed complement and thromboinflammatory proteins as top biomarkers, warranting diagnostic and therapeutic interrogation of these systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland.
- Department of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland.
- Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.
- Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
- Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
- Mount Sinai Clinical Intelligence Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
ORCID-Profile: Carlo Cervia-Hasler, Sarah C Brüningk, Tobias Hoch, Giulia Muzio, Ryan C Thompson, Laura Ceglarek, Roman Meledin, Patrick Westermann, Marc Emmenegger, Patrick Taeschler, Yves Zurbuchen, Michele Pons, Dominik Menges, Tala Ballouz, Sara Cervia-Hasler, Sarah Adamo, Miriam Merad, Alexander W Charney, Petter Brodin, Jakob Nilsson, Adriano Aguzzi, Miro E Raeber, Christoph B Messner, Noam D Beckmann, Karsten Borgwardt, Onur Boyman
Zitieren
APA
Cervia-Hasler, C., Brüningk, S. C., Hoch, T., Fan, B., Muzio, G., Thompson, R. C., Ceglarek, L., Meledin, R., Westermann, P., Emmenegger, M., Taeschler, P., Zurbuchen, Y., Pons, M., Menges, D., Ballouz, T., Cervia-Hasler, S., Adamo, S., Merad, M., Charney, A. W., …, & Boyman, O. (2024). Persistent complement dysregulation with signs of thromboinflammation in active Long Covid. Science, 383(6680). https://doi.org/10.1126/science.adg7942
Vancouver
Cervia-Hasler C, Brüningk SC, Hoch T, Fan B, Muzio G, Thompson RC, et al. Persistent complement dysregulation with signs of thromboinflammation in active Long Covid. Science. 2024;383(6680). doi:10.1126/science.adg7942
BibTeX
@article{CerviaHasler2024,
author = {Cervia-Hasler, Carlo and Brüningk, Sarah C and Hoch, Tobias and Fan, Bowen and Muzio, Giulia and Thompson, Ryan C and Ceglarek, Laura and Meledin, Roman and Westermann, Patrick and Emmenegger, Marc and Taeschler, Patrick and Zurbuchen, Yves and Pons, Michele and Menges, Dominik and Ballouz, Tala and Cervia-Hasler, Sara and Adamo, Sarah and Merad, Miriam and Charney, Alexander W and Puhan, Milo and Brodin, Petter and Nilsson, Jakob and Aguzzi, Adriano and Raeber, Miro E and Messner, Christoph B and Beckmann, Noam D and Borgwardt, Karsten and Boyman, Onur},
title = {Persistent complement dysregulation with signs of thromboinflammation in active Long Covid},
journal = {Science},
year = {2024},
volume = {383},
number = {6680},
doi = {10.1126/science.adg7942}
}
EUVIMED